Low Molecular Weight Dextran Infusions in Systemic Sclerosis with Raynaud's Phenomenon: A Report of Nine Cases
- 12 December 1970
- Vol. 4 (5736) , 657-659
- https://doi.org/10.1136/bmj.4.5736.657
Abstract
Two litres of low molecular weight dextran in normal saline were given intravenously over 48 hours to 10 patients with systemic sclerosis and Raynaud's phenomenon. The finger temperatures of nine were recorded under standardized conditions. One patient had lowered temperatures of the fingers, two had a rise in temperature, and six had no change. There were no side effects of the treatment. None of the 10 patients showed any clinical improvement.Keywords
This publication has 7 references indexed in Scilit:
- Low Molecular Weight DextranMedical Clinics of North America, 1967
- Renal failure associated with low-molecular-weight dextran infusion.BMJ, 1966
- THE EFFECT OF INTERMITTENT LOW MOLECULAR DEXTRAN INFUSIONS UPON THE DIGITAL CIRCULATION IN SYSTEMIC SCLEROSIS.British Journal of Dermatology, 1965
- LOW-MOLECULAR-WEIGHT DEXTRAN IN THE TREATMENT OF PERIPHERAL ARTERIAL INSUFFICIENCYThe Lancet, 1965
- LOW-MOLECULAR-WEIGHT DEXTRAN ('RHEOMACRODEX') IN ISCHÆMIC ULCERATION OF THE SKINThe Lancet, 1964
- RHEOMACRODEX IN PERIPHERAL ISCHEMIAThe Lancet, 1963
- A Standardized Breath Holding Technique for the Clinical Measurement of the Diffusing Capacity of the Lung for Carbon Monoxide 1Journal of Clinical Investigation, 1957